Current and historical daily PE Ratio for TRXPF (
Torii Pharmaceutical Co Ltd
) from 2009 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Torii Pharmaceutical stock (TRXPF) PE ratio as of Jun 19 2024 is 19.25.
More Details
Torii Pharmaceutical Co Ltd (TRXPF) PE Ratio (TTM) Chart
Torii Pharmaceutical Co Ltd (TRXPF) PE Ratio (TTM) Historical Data
View and export this data going back to 2009. Start your Free Trial
Total 1251
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Torii Pharmaceutical PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 19.0 | 2024-04-16 | 19.0 |
2024-06-18 | 19.0 | 2024-04-15 | 19.0 |
2024-06-17 | 19.0 | 2024-04-12 | 19.0 |
2024-06-14 | 19.0 | 2024-04-11 | 19.0 |
2024-06-13 | 19.0 | 2024-04-10 | 19.0 |
2024-06-12 | 19.0 | 2024-04-09 | 19.0 |
2024-06-11 | 19.0 | 2024-04-08 | 19.0 |
2024-06-10 | 19.0 | 2024-04-05 | 19.0 |
2024-06-07 | 19.0 | 2024-04-04 | 19.0 |
2024-06-06 | 19.0 | 2024-04-03 | 19.0 |
2024-06-05 | 19.0 | 2024-04-02 | 19.0 |
2024-06-04 | 19.0 | 2024-04-01 | 19.0 |
2024-06-03 | 19.0 | 2024-03-28 | 19.0 |
2024-05-31 | 19.0 | 2024-03-27 | 24.3 |
2024-05-30 | 19.0 | 2024-03-26 | 24.3 |
2024-05-29 | 19.0 | 2024-03-25 | 24.3 |
2024-05-28 | 19.0 | 2024-03-22 | 24.3 |
2024-05-24 | 19.0 | 2024-03-21 | 24.3 |
2024-05-23 | 19.0 | 2024-03-20 | 24.3 |
2024-05-22 | 19.0 | 2024-03-19 | 24.3 |
2024-05-21 | 19.0 | 2024-03-18 | 24.3 |
2024-05-20 | 19.0 | 2024-03-15 | 24.3 |
2024-05-17 | 19.0 | 2024-03-14 | 24.3 |
2024-05-16 | 19.0 | 2024-03-13 | 24.3 |
2024-05-15 | 19.0 | 2024-03-12 | 24.3 |
2024-05-14 | 19.0 | 2024-03-11 | 24.3 |
2024-05-13 | 19.0 | 2024-03-08 | 24.3 |
2024-05-10 | 19.0 | 2024-03-07 | 24.3 |
2024-05-09 | 19.0 | 2024-03-06 | 24.3 |
2024-05-08 | 19.0 | 2024-03-05 | 24.3 |
2024-05-07 | 19.0 | 2024-03-04 | 24.3 |
2024-05-06 | 19.0 | 2024-03-01 | 24.3 |
2024-05-03 | 19.0 | 2024-02-29 | 24.3 |
2024-05-02 | 19.0 | 2024-02-28 | 24.3 |
2024-05-01 | 19.0 | 2024-02-27 | 24.3 |
2024-04-30 | 19.0 | 2024-02-26 | 24.3 |
2024-04-29 | 19.0 | 2024-02-23 | 24.3 |
2024-04-26 | 19.0 | 2024-02-22 | 24.3 |
2024-04-25 | 19.0 | 2024-02-21 | 24.3 |
2024-04-24 | 19.0 | 2024-02-20 | 24.3 |
2024-04-23 | 19.0 | 2024-02-16 | 24.3 |
2024-04-22 | 19.0 | 2024-02-15 | 24.3 |
2024-04-19 | 19.0 | 2024-02-14 | 24.3 |
2024-04-18 | 19.0 | 2024-02-13 | 24.3 |
2024-04-17 | 19.0 | 2024-02-12 | 24.3 |
Torii Pharmaceutical Co Ltd (TRXPF) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Torii Pharmaceutical Co Ltd
ISIN : JP3635800000
Share Class Description:
TRXPF: Ordinary SharesDescription
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.